Akèy › Skleroz Miltip › Ohio
Etid klinik pou Skleroz Miltip nan Ohio
14 etid pou Skleroz Miltip ap chèche patisipan nan sit nan Ohio.
Vil nan Ohio
Tèks ofisyèl etid la (Anglè)
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 104, Columbus
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 25, 2026 · NCT07840326Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Centerville
- TG Therapeutics Investigational Trial Site, Centerville
- TG Therapeutics Investigational Trial Site, Cincinnati
- ak 4 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Cincinnati, Cincinnati
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07477639RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cleveland Clinic, Cleveland
- The Ohio State University, Department of Psychiatry, Columbus
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- The Ohio State University- Site Number : 8400009, Columbus
- The Boster Center for Multiple Sclerosis- Site Number : 8400006, Columbus
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT07325292A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- University of Cincinnati Medical Center, Cincinnati
- Riverside Methodist Hospital, Columbus
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06782490A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Cleveland
- TG Therapeutics Investigational Trial Site, Columbus
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Research Site, Cleveland
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou Aug 25, 2026 · NCT07224373Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis
- Louis Stokes Cleveland VA Medical Center, Cleveland
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07768761Understanding and Enhancing Human Health and Movement
- Louis Stokes Cleveland VA Medical Center, Cleveland
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07738978Care in Multiple Sclerosis (MS)
- Cleveland Clinic, Cleveland
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT07011914Central Vein Sign in Multiple Sclerosis Extension Study
- Cleveland Clinic Foundation, Cleveland
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Feb 20, 2026 · NCT07424027Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
- Cleveland State University, Cleveland
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Sep 24, 2025 · NCT05964829Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.